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INTRODUCTION
Background 
 
Global left ventricular (LV) systolic function, most commonly assessed by 
echocardiographic ejection fraction (EF), is an important predictor of outcome.1 Although it is 
commonly used to evaluate ventricular function, the measurement of EF presents a number of 
challenges related to image quality, assumptions of ventricular geometry, expertise and is 
limited to assessing changes in ventricular cavity size during the cardiac cycle. The traditional 
volume measurement-based echocardiographic parameters are indirect means of assessing 
myocardial function, and are insensitive to early changes in cardiomyopathy.2 Furthermore, 
the assessment of global LV function by EF is based on 2 apical views only, and might 
underestimate deterioration in regional LV function. Echocardiographic assessment of EF is 
easily available and feasible, but does not provide information on segmental and layer-
specific ventricular function. Increased compensatory contractions in healthy myocardial 
regions may result in only minor alterations in EF, and may conceal large areas with impaired 
function. Echocardiographic techniques allow the assessment of strain, a measure of 
myocardial deformation, an intrinsic mechanical property, that measures myocardial systolic 
function more directly compared to conventional cavity-based echocardiographic parameters.3 
It is a dimensionless measure of the deformation that occurs upon application of stress. It 
represents the fractional or percentage change between the unstressed and stressed dimension. 
Furthermore, recent software allows separate evaluation of endocardial, mid-myocardial and 
epicardial myocardial deformation.  
In this thesis, we evaluated the ability of strain echocardiographic techniques to assess 
subtle myocardial alterations in order to improve prognostic information in patients with 
arrhythmogenic right ventricular cardiomyopathy (ARVC), in heart transplant (HTx) 
recipients and in patients with non-ST elevation (NSTE) acute coronary syndrome (ACS).  
9 
 
Ventricular function and mechanical dispersion in ARVC 
 
ARVC is a chronic, progressive, heritable cardiomyopathy and is one of the leading 
causes of sudden unexpected cardiac death in previously healthy young individuals.4 It was 
initially recognized as a disease of the right ventricle (RV), but involvement of the left 
ventricle (LV) is now commonly recognized.5-7 Four clinical stages have been documented: 
an early concealed phase, overt electrical disorder, isolated right heart failure, and 
biventricular pump failure.8  
 Recent molecular genetic reports have revealed ARVC as mainly an autosomal 
dominant inherited desmosomal disease,9 leading to progressive loss of cardiac myocytes, 
followed by fibro-fatty replacement. Penetrance is age and gender dependent and the 
progressive clinical picture is highly variable.10 Importantly, life-threatening arrhythmia may 
be the first clinical sign and may occur with only discrete or even absent myocardial structural 
changes.11, 12 Risk stratification of so far asymptomatic mutation carriers is therefore 
challenging.  
Echocardiographic studies of the RV in ARVC patients have shown that RV dilatation 
and reduced regional or global RV function are traits of the disease. Quantitative assessment 
of RV function is difficult due to complicated anatomy and load dependency. Reviewed 
guidelines for diagnosing ARVC from 2010 have improved quantitative assessment of RV 
dysfunction, including measures of RVOT and RV area.13  
Electrical conduction delay with consequent electrical dispersion has been suggested 
as a mechanism of ventricular arrhythmia in ARVC patients.14, 15 Mechanical dispersion 
(heterogeneous contraction) can be assessed by strain echocardiography and may reflect 
electrical dispersion. Mechanical dispersion has recently been demonstrated to relate to 
malignant ventricular arrhythmias in long QT syndrome,16 after myocardial infarction,17 and 
in dilated cardiomyopathy.18  
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The first clinical symptom in ARVC patients may present as life-threatening 
arrhythmia. Unfortunately, there is no single test to diagnose or exclude ARVC and to predict 
arrhythmias. Therefore, there is a need for methods identifying patients with increased risk for 
ventricular arrhythmias. 
In the first paper, we focused on the prediction of arrhythmias in patients with ARVC 
and assessment of LV and RV function in asymptomatic mutation carriers and ARVC 
patients. The presence of malignant arrhythmias and reduced LV and RV function are 
important prognostic factors in these patients. 
 Ventricular function in HTx recipients 
 
End-stage heart failure is a significant problem in the Western world. Cardiac 
transplantation remains the gold standard therapy for patients with end-stage heart failure, 
with 1-year survival approaching 90%.19 Graft dysfunction is a major cause of morbidity and 
mortality in HTx recipients.20 Advances in the treatment of antibody mediated rejection and 
acute cellular rejection have increased early transplant survival.19 However, not all cases of 
cardiac allograft dysfunction can be explained by the currently known histopathologic 
mechanisms of allograft rejection.21 
The search for non-invasive techniques to assess cardiac allograft function remains a 
priority objective for HTx professionals. Global LV systolic function, most commonly 
assessed by echocardiographic EF has, however, several limitations as described earlier. In 
addition, EF tends to be stable over time and do not always correlate with biopsy-proven 
rejection or time after transplantation.22 
Although LV global longitudinal strain (LVGLS) has been used in a growing number 
of clinical conditions, the association between reduced LVGLS and risk for mortality in HTx 
recipients is uncertain. 
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Ventricular function in patients with CAD 
 
The clinical presentation of coronary artery disease (CAD) varies from silent ischemia, 
stable angina pectoris to ACS and death. ACS comprises NSTE-ACS and ST-elevation 
myocardial infarction (STEMI). The presence of ST-elevation typically represents coronary 
occlusion requiring acute reperfusion therapy. In contrast, patients with suspected NSTE-ACS 
have more heterogeneous findings on coronary angiography. Coronary occlusion and/or 
significant stenosis may or may not be present, however,  revascularization therapy is 
performed in about two thirds of these patients.23  
The LV wall of the heart comprises an endocardial, a mid-myocardial and an 
epicardial layer. Of these 3 layers, the endocardium undergoes the greatest deformation 
during systole, including thickening and shortening, and is most susceptible to ischemic 
injury.24-26 Recent software allows separate evaluation of endocardial, mid-myocardial and 
epicardial myocardial deformation. Careful evaluation of these layers might increase the 
diagnostic accuracy of CAD in patients with NSTE-ACS. 
 
In this thesis, patients from the above mentioned categories were included with the 
overall aim of improving assessment of ventricular function by echocardiographic techniques. 
Detection of subtle myocardial alterations with these techniques may facilitate more accurate 
prediction of prognosis and may guide treatment that might improve prognosis in these 
patients.  
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AIMS OF THE THESIS 
General aim 
 
To assess ventricular function by strain echocardiography in patients with ARVC, HTx 
recipients and patients with significant CAD, in order to facilitate early detection of subtle 
myocardial alterations in these patients. 
Specific aims 
 
I. To evaluate if pronounced RV and LV mechanical dispersion by myocardial strain is 
associated with susceptibility to ventricular arrhythmia in patients with ARVC and 
therefore may be an additional tool for arrhythmia risk stratification (Paper 1).  
 
II. To investigate to what extent LV function assessed by strain echocardiography was 
reduced along with RV function in patients with ARVC diagnosis and in 
asymptomatic mutation carriers (Paper 1). 
 
III. To evaluate to what extent reduced LV function assessed by GLS, 1-3 weeks after 
HTx is associated with increased 1-year mortality, compared to other more established 
prognostic factors, such as recipient and donor age, renal function and right heart 
catheterization parameters (Paper 2). 
 
IV. To evaluate if endo-, mid- and epicardial deformation assessed by layer-specific strain 
echocardiography could identify significant CAD in patients with suspected NSTE-
ACS (Paper 3). 
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MATERIAL 
Study population (Paper 1) 
 
 In total, 69 patients were included. Of these, 42 were index patients referred to our 
centre for ventricular tachycardia (VT) or ventricular fibrillation (VF) evaluation and in 
whom the diagnosis of ARVC was originally made based on the International Task Force 
criteria from 1994. After the revision of the International Task Force criteria in 2010,13 the 
diagnosis of all ARVC patients was reviewed. First degree relatives of mutation positive 
ARVC index patients underwent cascade genetic screening. Of all screened individuals, 27 
tested positive for the ARVC mutation found in the index patient. Importantly, none of the 
included mutation positive family members had symptoms of the disease in terms of 
palpitations, syncopes, arrhythmias or heart failure and were defined as asymptomatic 
mutation carriers. 
ARVC related mutations were confirmed in 54 (78%) of all patients, [47 (68%) PKP2, 
6 (9%) DSP and 1 (1%) RYR2]. In ARVC patients with arrhythmias, 27 (64%) had ARVC 
related mutations [23 (55%) PKP2, 3 (7%) DSP and 1 (2%) RYR2]. No mutations were found 
in 15 (36%) ARVC patients. In asymptomatic mutation carriers 24 (89%) had PKP2 and 3 
(11%) had DSP mutations.
The control group consisted of 30 healthy individuals from the hospital staff. Ten 
healthy mutation negative family members were included after family cascade genetic 
screening. They were added to explore if RV mechanical dispersion was attributed to the 
familial ARVC related genetic mutation or to other unidentified familial factors. All 
individuals in the control group had normal electrocardiogram (ECG), physical examination, 
and echocardiographic study and were free from disease with potential impact on the 
cardiovascular system. 
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Study population (Paper 2) 
 
 In total, 176 consecutive adult primary orthotopic HTx recipients, transplanted at the 
national HTx centre (Oslo University Hospital, Rikshospitalet) between August 2001 and 
August 2007, were retrospectively evaluated for eligibility in this study. Of these patients, 167 
had an analyzable echocardiographic study, performed 13 ± 6 days post HTx. Assessment of 
LVGLS was not feasible due to poor image quality in 1 (6%) non-survivor and 8 (5%) 
survivors. 
 Patients were identified, and the data were collected from our transplant database 
approved by The Institutional Review Board, the hospital dialysis records and the Norwegian 
Cancer Registry. Data contains information after HTx, including demographics, clinical 
history, treatment, examinations and records of hemodynamic data and renal replacement 
therapy including kidney transplantation. The database is updated continuously as we cross 
match data from the National Norwegian Population Registry, general hospital registry, 
Norwegian Cancer Registry and the immunology and pathology registry.  
During the first year, 15/167 (9%) patients died 86 ± 72 days after HTx. The primary 
cause of death was grade 2R or higher acute cellular rejection27 in 2 patients. Importantly, a 
combination of acute cellular rejection and antibody mediated rejection was present in 7 cases 
at the time of death. The primary causes of death in the other 6 patients were multiple organ 
dysfunction syndrome in combination with sepsis in 3 and in combination with acute 
respiratory distress syndrome in 1, peroperative myocardial infarction and post-operative 
ventricular arrhythmia in 1, and heparin induced bleeding in 1 HTx recipient. Among the 
survivors (n=152), 48 (32%) experienced 1 or more episodes of biopsy proven grade 2R or 
higher acute cellular rejection and 8 (5%) experienced antibody mediated rejection within the 
first year.  
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Study population (Paper 3) 
 
This study was conducted in a single tertiary coronary care center. Seventy-seven 
patients fulfilled inclusion criteria with symptoms and signs of NSTE-ACS and were referred 
to our hospital for coronary angiography. These patients were prospectively included in the 
study. 
Exclusion criteria were: age <18 years, history of previous myocardial infarction, 
percutaneous coronary intervention and open chest surgery, left bundle branch block, severe 
valvular dysfunction, atrial fibrillation with heart rate >100 bpm, sustained severe arrhythmia, 
or any condition which interfered with the patients' ability to comply.  
ECGs were evaluated by experienced cardiologists at admission. ECGs were described 
as ischemic if ST depression or T wave changes were present. Echocardiography was 
performed 1-2 hours prior to coronary angiography and within 48 after the last episode of 
chest pain. 
By coronary angiography, 49 (64%) had significant CAD. Patients with significant 
CAD were more frequently male compared to patients without. No differences in age, co-
morbidity or medication were observed between those with and without significant CAD at 
admission. Of the patients with significant CAD, 21 (28%) had significant coronary stenosis, 
and 28 (36%) had coronary artery occlusion in 1 or more coronary arteries.   
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METHODS 
Two-dimensional echocardiography  
 
Patients and control subjects underwent an echocardiographic study by Vivid 5 and 7 
(GE, Vingmed, Horten, Norway) in study 1 and 2, and by ARTIDA (Toshiba Medical 
Systems Corporation, Tokyo, Japan) in study 3. Cineloops from 3 standard apical views (4-
chamber, 2-chamber and apical long-axis) were recorded using grey-scale harmonic imaging 
in all 3 studies. In study 3, also standard parasternal short-axis view of the LV at the level of 
the papillary muscle was recorded. Data were digitally stored for off-line analysis using 
software (EchoPac, GE, Vingmed) in study 1 and 2, and (Toshiba Medical Systems 
Corporation, Tokyo, Japan) in study 3. The echocardiographic data were analyzed blinded to 
all clinical information.  
EF was assessed by the modified biplane Simpson`s method from apical 4- and 
2-chamber grey-scale recordings in all 3 studies. End-diastole was defined as the frame 
closest to the R-wave, and end-systole was defined as the minimal cavity area just before 
mitral valve opening. According to the recommendations of the American Society of 
Echocardiography, the inner contour of the LV cavity was manually traced, leaving the 
papillary muscles and trabeculations within the cavity.28  In all 3 papers, EF was compared to 
different strain parameters as a major part of the studies. 
From 2D echocardiography the following additional parameters were assessed in the 
first study: right ventricular outflow tract (RVOT) diameter in the parasternal short axis view, 
RV end-diastolic area, RV end-systolic area and RV fractional area change (RVFAC) from 
apical 4 chamber view. 13 
In the third study, wall motion was visually assessed in a 16-segment model, as 
normal=1, hypokinetic=2, akinetic=3, dyskinetic=4, aneurysm=5, according to the American 
Society of Echocardiography.29 Image quality was evaluated and segments were discarded if 
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the quality were found insufficient for analysis. Wall motion score index (WMSI) was 
calculated for each patient as the average of analyzed segmental values.  
Two-dimensional speckle-tracking echocardiography 
 
Strain is a clinical index of regional myocardial deformation30  and have been 
introduced and validated using magnetic resonance imaging (MRI) tagging31 and 
sonomicrometry.32 Tissue Doppler technology, the predecessor of speckle-tracking 
technology, requires achievement of parallel orientation between the direction of motion and 
the ultrasound beam. Its use has remained limited due to angle dependency, substantial 
intraobserver and interobserver variability and noise interference. Strain is defined as tissue 
elongation relative to length. A positive strain value refers to elongation, whereas a negative 
strain value describes shortening. Therefore, negative systolic strain values describe a normal 
contracting myocardial segment (Figure 1).  
 
Figure 1. Left  panel demonstrate apical 4-chamber view with the left ventricular (LV) 
myocardium as region of interest in a healthy individual. Corresponding longitudinal strain 
curves are shown in the right  panel. End-systole is defined by aortic valve closure (AVC), 
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and is marked by a vertical stippled blue line. Peak systolic strain is defined as maximum 
shortening during systole (arrow). 
RV = right ventricle 
 
Two-dimensional speckle-tracking echocardiography (2D-STE) has been developed to 
eliminate the problem of angle-dependency in Doppler-derived deformation analyses.33 It is a 
semi-automated quantitative technique for assessment of cardiac function based on gray-scale 
images. Strain (relative tissue deformation) is evaluated on a frame-by-frame basis by 
tracking of acoustic markers (speckles) throughout the cardiac cycle and is calculated for each 
LV segment as the average relative deformation in longitudinal (Paper 1-3), circumferential 
(Paper 3), or radial directions (Figure 2).  
 
Figure 2. Schematic illustration of the 3 strain directions in the heart's coordinate system. 
 CS = circumferential strain, LS = longitudinal strain and RS = radial strain. 
 
The endocardial borders were traced in the end-systolic frame of the 2D images from 
the 3 apical views for LV longitudinal strain (Paper 1-3), from the 4-chamber view for RV 
longitudinal strain (Figure 3) (Paper 1) and from short axis view for LV circumferential strain 
(Paper 3).  
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Figure 3. Left  panel demonstrate apical 4-chamber view with the RV  myocardium as region 
of interest in a healthy individual. Corresponding longitudinal strain curves are shown in the 
right  panel.  
AVC = aortic valve closure; LV = left ventricle 
 
The thickness of the region of interest was adjusted to match the thickness of the 
myocardial wall. Speckles were tracked throughout the cardiac cycle. Segments that failed to 
track were manually adjusted by the operator. Any segments that subsequently failed to track 
were excluded. The software generated 18 longitudinal LV segments from the 3 apical views 
which were converted to a standardized 16 LV segment model by averaging the strain values 
of corresponding apical segments in the apical long-axis and 4-chamber planes.29 
Consequently, peak systolic longitudinal strain, defined as maximum systolic longitudinal 
shortening, was assessed in 16 longitudinal LV segments and averaged to GLS (Paper 1-3). 
Peak systolic longitudinal strain from 3 RV free wall segments was averaged as a measure of 
RV function (RV strain) (Paper 1). Finally, global circumferential strain (GCS) was averages 
from peak systolic circumferential strain in 6 circumferential LV segments (Paper 3). End of 
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systole was defined by the timing of the aortic valve closure in apical long axis view (Paper 1-
3). 
Two-dimensional strain and mechanical dispersion 
 
The endocardial borders were traced as described earlier and speckles were tracked in 
the LV and the RV myocardium throughout the cardiac cycle. Contraction duration (CD) 
(Figure 4) was measured as the time from onset R on ECG to maximum LV and RV 
myocardial shortening by strain. 
 
Figure 4. Mechanical dispersion in an asymptomatic mutation carrier (left panel) and a 
patient with arrhythmogenic right ventricular cardiomyopathy (ARVC) with recurrent 
arrhythmias (right panel). Horizontal white arrow indicates contraction duration defined as 
the time from onset R on ECG to maximum myocardial shortening. Vertical arrows indicate 
the timing of maximum myocardial shortening in each segment. Right panel shows more 
pronounced mechanical dispersion.34 
 
 Standard deviation of CD was calculated as a parameter of mechanical dispersion, in a 
16 LV segment and a 6 RV segment model. We used a 6 RV segment model (3 RV free wall 
segments plus 3 septal segments) when assessing mechanical dispersion which includes the 
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usually less affected interventricular septum to elucidate dispersion of contraction between 
affected and non-affected segments (Figure 5). 
Figure 5. Right ventricular strain curves in a healthy control, an asymptomatic carrier of 
arrhythmogenic right ventricular cardiomyopathy (ARVC) specific mutation, and a patient 
with manifest ARVC. Mechanical dispersion is gradually increasing as the disease is 
progressing. 
Two-dimensional layer-specific strain 
 
The endocardial borders were traced in the end-systolic frame from the 3 apical views 
for analyses of longitudinal and from parasternal short-axis view for circumferential 
endocardial, mid-myocardial and epicardial strains. Peak negative systolic longitudinal and 
circumferential strains from 3 layers were assessed using off-line software (Toshiba Medical 
Systems Corporation, Tokyo, Japan) in 16 longitudinal (Figure 6) and 6 circumferential LV 
segments. All segmental values were averaged to GLS and GCS for each myocardial layer. 
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Figure 6. Six endocardial longitudinal strain segments in apical 4-chamber view in a patient 
with non-ST elevation (NSTE) acute coronary syndrome (ACS) with occluded Left 
Circumflex (LCX) artery. Automatic strain analysis shows reduced color coded endocardial 
strain values in the segments supplied by the LCX artery on the left. Color-coding from yellow 
to green indicates strain from +30% to -30%. Yellow indicates preserved strain. Brown 
indicates areas with reduced strain. Epicardial shortening was assessed along the red line. 
Strain curves for the 6 endocardial segments are displayed on the right. The curves 
representing the segments supplied by the LCX artery show reduced peak systolic 
longitudinal strain values of -15% (white arrow).35  
 
Endo-, mid-, and epicardial territorial longitudinal strains (TLS) were calculated based 
on the perfusion territories of the 3 major coronary arteries in a 16-segment LV model,29 by 
averaging all segmental peak systolic longitudinal strain values within each territory in each 
layer. 
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Magnetic Resonance Imaging 
  
Due to its high reproducibility and high spatial resolution, MRI is considered as the 
gold standard for cardiac deformation and scar imaging. In addition, MRI can detect fatty 
replacement of myocardium and scar tissue in patients with ARVC.  
In Paper 1, MRI was performed using 1.5 Tesla units (Magnetom Vision Plus or 
Magnetom Sonata, Siemens, Erlangen, Germany) and a phased array body coil. Axial and 
sagital T1 TSE images, multiple axial and one sagital cineloop covering the RV and LV were 
recorded. RV and LV chamber dimensions, wall thickness and myocardial function were 
assessed. A negative MRI study was defined as normal RV and LV dimensions, normal 
global and regional wall-motion, no fatty infiltration and/or scar tissue, and no aneurysm 
formation.  
Signal-Averaged ECG  
 
Signal-averaged electrocardiography (SAECG) is a method, in which multiple ECG 
signals are averaged to remove interference and reveal small variations in the QRS complex, 
usually called "late potentials". These may represent a predisposition for ventricular 
arrhythmias.36 
In Paper 1, SAECG was performed using a MAC® 5000-analysing system (GE 
Medical Systems, Milwaukee, WI, USA). Time domain analysis was obtained in the bandpass 
filter 40 to 250 Hz. The SAECG was considered positive for late potentials when at least 2 of 
the following 3 parameters were abnormal: total filtered QRS duration (fQRSd) >114 ms, the 
terminal (last 40ms) QRS root mean square voltage (RMS) <20μV and the low amplitude 
(<40μV) late potential duration (HFLA) >38 ms. 
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Right heart catheterization 
 
In severe heart failure, pulmonary artery pressures may increase. To assess 
hemodynamics in the follow up of HTx recipients after a successful heart transplantation, 
right heart catheterization was performed and pulmonary pressures and pulmonary vascular 
resistance (PVR) were measured since these parameters are important prognostic factors. 
In Paper 2, right heart catheterization was performed using a Swan-Ganz pulmonary 
artery thermodilution catheter (Baxter Health Care Corp, Santa Ana, CA) 12 ± 8 days post-
HTx. Mean pulmonary artery pressures and mean pulmonary capillary wedge pressures were 
obtained. Cardiac output was measured by thermodilution. The transpulmonary gradient was 
obtained by subtracting mean pulmonary capillary wedge pressure from mean pulmonary 
artery pressure. PVR was obtained in Wood units by dividing transpulmonary gradient with 
cardiac output. 
Coronary angiography 
 
In Paper 3, all patients underwent coronary angiography. The assessment of CAD was 
performed by visual estimate in each single stenosis with multiple projections, avoiding 
overlap of side branches and foreshortening of relevant coronary stenoses. Coronary 
occlusion was defined as TIMI flow 0 or 1, while significant coronary artery stenosis was 
considered as ≥50% reduction of vessel diameter in at least one major coronary artery. 
Fractional flow reserve (FFR) measurement was performed in case the operator was in doubt 
about the hemodynamic significance of a stenosis. The lesion was considered functionally 
significant when FFR ≤0.8. When judged appropriate given angiographic, ECG and clinical 
data, intervention was performed. 
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Reproducibility and feasibility 
 
In Paper 1, intraobserver and interobserver intraclass correlation were 0.96 and 0.95, 
for RV strain measurements, 0.94 and 0.94 for LVGLS measurements, 0.85 and 0.84 for RV 
time measurements and 0.93 and 0.88 for LV time measurements, respectively. 
In Paper 2, intraobserver and interobserver intraclass correlation for LVGLS were 0.91 
and 0.88. 
In Paper 3, assessment of longitudinal strain could be performed in 1303 (94%) 
endocardial, 1149 (83%) mid-myocardial and 1142 (82%) epicardial LV segments. The 
corresponding circumferential analyses could be done in 361 (78%) endocardial, 361 (78%) 
mid-myocardial and 343 (74%) epicardial segments. Intraobserver and interobserver 
intraclass correlation were 0.96 and 0.96, for endocardial GLS, 0.87 and 0.92, for mid-
myocardial GLS, 0.94 and 0.93 for epicardial GLS, 0.81 and 0.84, for endocardial GCS, 0.84 
and 0.81, for mid-myocardial GCS and 0.82 and 0.76 for epicardial GCS measurements, 
respectively. 
Statistical methods 
 
Analyses were carried out using a standard statistical software program (SPSS version 
16, SPSS Inc, Chicago, IL). Data were presented as mean ± standard deviation, numbers and 
percentages, and median and interquartile range (IQR)(Paper 1-3). For normally distributed 
variables, chi-square test (categorical variables) and Student`s t-test (continuous variables) 
were used to determine differences between two groups (Paper 1-3). For comparisons 
between more than two groups, analysis of variance (ANOVA) was performed with the 
Bonferroni post hoc correction for multiple comparisons (Paper 1 and 3). For non-normally 
distributed variables, the Mann-Whitney U-test (2 groups)(Paper 1-3) and the Kruskal-Wallis 
test (multiple groups)(Paper1) were used. Logistic regression analysis was performed to 
determine the independent prognostic value of RV dispersion for predicting arrhythmias in 
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ARVC patients and asymptomatic mutations carriers (Paper 1) and to determine the 
diagnostic value of endocardial TLS for predicting significant CAD in patients with suspected 
NSTE-ACS (Paper 3). The selection of variables to be included in a multivariate logistic 
regression analysis in Paper 1 was based on statistical significance of p<0.05 in the univariate 
logistic regression analysis, in addition to the LVEF which was forced in. In Paper 3, 
multivariate logistic regression analysis was performed for factors that could potentially 
influence myocardial function and strain measurements and to determine the independent 
diagnostic value of endocardial TLS for predicting significant CAD. The area under the 
receiver-operating characteristic (ROC) curve (AUC) was calculated for LVEF, LVGLS, RV 
strain, RVFAC and RV mechanical dispersion in Paper 1, for recipient age, donor age, LVEF, 
LVGLS, PVR and C-reactive protein in Paper 2 and for endo-, mid-, epicardial TLS, GLS and 
GCS, WMSI, EF and Troponin T in Paper 3. Comparisons between AUCs were performed by 
using a non-parametric U-test (Analyze-it®) (Paper 1-3). The value closest to the upper left 
corner of the ROC curves determined optimal sensitivity and specificity for the ability of the 
parameters to discriminate between those with and without arrhythmic events in Paper 1, to 
predict 1-year mortality in HTx recipients in Paper 2 and to predict the presence of significant 
CAD in NSTE-ACS patients in Paper 3. Correlation between the RV and LV strain was 
assessed by linear regression analysis in Paper 1. Correlation of strain parameters with 
Troponin T was tested by the Spearman correlation coefficient in Paper 3.  
In Paper 2, univariate Cox regression analysis was performed to determine predictors 
for 1-year mortality among baseline clinical features, right heart catheterization parameters, 
biochemical markers and measures of LV function. The variables recipient age, pulmonary 
vascular resistance, LVGLS, LVEF and CRP with a univariate statistical significance of < 
0.05 were selected for inclusion in a multivariate Cox regression analysis to determine the 
independent prognostic value of LVGLS for predicting 1-year mortality. Survival was 
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expressed using Kaplan-Meier analysis long-rank tested for significance. We calculated the 
integrated discrimination index (IDI) and the net reclassification improvement (NRI) between 
models following the methodology of Pencina et al 37, 38 in Paper 2.  
Reproducibility was expressed as intraclass correlation coefficient and was performed 
in 10 patients in each study.  
P-values were two-tailed and values <0.05 were considered significant in all 3 papers. 
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SUMMARY OF RESULTS 
Paper 1 
 
We included 69 patients, 42 (61%) had symptomatic ARVC and 27 (39%) were 
mutation positive asymptomatic family members, diagnosed by cascade genetic screening. 
Forty healthy individuals served as controls. Ventricular arrhythmias (VT/VF) were 
documented in all 42 ARVC patients. 
Mechanical dispersion was more pronounced in ARVC patients with arrhythmias 
compared to asymptomatic mutation carriers and healthy individuals in RV (52 [41, 63] ms vs 
35 [23, 47] ms vs 13 [9, 19] ms, p<0.001). A ROC analysis demonstrated that RV mechanical 
dispersion was the most sensitive and specific parameter to identify arrhythmic events among 
the study participants (Figure 7). Furthermore, mechanical dispersion was more pronounced 
in asymptomatic mutation carriers compared to healthy individuals (p<0.001). RV mechanical 
dispersion predicted ventricular arrhythmias in a multivariate logistic regression analysis 
(p<0.03) with odds ratio 1.66 (95% Confidence Interval 1.06-2.58). RV and LV function by 
strain (-19 [-16, -21] % and -17 [-16, -19] %) were reduced in symptomatic ARVC patients 
and correlated significantly (R=0.81, p<0.001). RV and LV strain were reduced in 
asymptomatic mutation carriers compared to healthy individuals (-22 [-20, -24] % vs -25 [-23, 
-27] % and -20 [-18, -21] % vs -22 [-21, -24] %, both p<0.001). 
RV mechanical dispersion was pronounced in patients with ARVC with ventricular 
arrythmias. RV mechanical dispersion was present in asymptomatic mutation carriers and 
may be helpful in risk stratification. RV and LV function correlated in ARVC patients 
implying that ARVC is a biventricular disease.  
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Figure 7. Receiver-operating characteristic curve analyses for the ability of LV and RV 
parameters to predict arrhythmic events in ARVC patients, asymptomatic mutation carriers 
and healthy controls (n=109).34  
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Paper 2 
 
 LV function can be accurately assessed by 2D-STE. The association between reduced 
LVGLS magnitude and risk for mortality in HTx recipients is unclear. We hypothesized that 
LVGLS could predict 1-year mortality in HTx recipients. 
We retrospectively evaluated 176 consecutive adult primary single organ orthotopic 
HTx recipients. Of these, 167 had acceptable echocardiographic image quality and were 
included in the study. N-terminal probrain natriuretic peptide, creatinine, C-reactive protein 
and invasive hemodynamic parameters were measured and echocardiography was performed 
1-3 weeks post HTx. LVGLS was averaged from regional strain in 16 LV segments.  
During the first year, 15 (9%) patients died 86 ± 72  days after HTx. LV function 
assessed by LVGLS and LVEF was significantly decreased in non-survivors (-7.9 [-5.7,-10.8] 
% and 34 [30, 42] %) compared with survivors (-13.7 [-11.8, -15.4] % and 46 [41, 54%], 
p<0.001 respectively). Non-survivors were older and had higher donor age. Mean pulmonary 
capillary wedge pressure was similar in the two groups while all other hemodynamic 
parameters were increased in non-survivors (p<0.05). LVGLS was the only significant 
(p=0.02) non-invasive independent predictor with hazard ratio 1.42 (95% Confidence Interval 
1.07-1.88, p=0.02) per 1 % decrease in strain magnitude, while PVR was a significant 
(p<0.001) invasive predictor with hazard ratio 3.98 (95% Confidence Interval 2.01-7.87) of 1-
year mortality in a multivariate Cox regression analysis. Kaplan-Meier survival analysis 
showed that patients with LVGLS ≥ -9% and LVEFs < 42% had significantly worse 
cumulative survival compared to HTx recipients with LVGLS < -9% and LVEFs ≥ 42% (log-
rank test, p<0.001) (Figure 8). By ROC analysis, LVGLS ≥ -9% showed the greatest AUC 
and predicted 1-year mortality with better sensitivity and specificity than LVEF < 42% 
(Figure 9). Including LVGLS to the prediction model improved classification of risk; relative 
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integrated discrimination index (IDI) was 3.4 (p<0.01), and net reclassification improvement 
(NRI) was 0.19 (95% CI 0.05-0.34, p<0.01).  
Reduced LV function and increased PVR are related to poor prognosis in HTx 
recipients. Early assessment of LVGLS might be a non-invasive predictor of 1-year mortality 
in these patients. 
 
 
 
Figure 8. Kaplan-Meier Survival analysis in 167 heart transplant recipients (15 non-
survivors and 152 survivors). Patients with LVGLS < -9% and LVEF ≥ 42% show 
significantly higher cumulative survival at 1-year of follow up.39  
LVEF, left ventricular ejection fraction; LVGLS, left ventricular global longitudinal strain 
32 
 
 
Figure 9.  Receiver-operating characteristic curve analyses for the ability of recipient age, 
donor age, PVR, LVGLS, LVEF, and C-reactive protein to predict 1-year mortality in HTx 
recipients. The analyses include all study participants (n=167).39 
AUC, area under the curve; CI, confidence interval; CRP, C-reactive protein; LVEF, left 
ventricular ejection fraction; LVGLS, left ventricular global longitudinal strain; PVR, 
pulmonary vascular resistance 
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Paper 3 
 
Seventy-seven patients referred to coronary angiography due to suspected NSTE-ACS 
were prospectively included. Coronary occlusion was found in 28, significant stenosis in 21 
and no stenosis in 28 patients. Echocardiography was performed 1-2 hours before 
angiography.  
Patients with significant CAD had worse function in all 3 myocardial layers assessed 
by TLS and GCS compared to patients without significant CAD. Endocardial TLS (-14.0 ± 
3.3% vs -19.2 ± 2.2%, p<0.001) and GCS (-19.3 ± 4.0% vs -24.3 ± 3.4%, p<0.001) were most 
affected. The absolute difference between endo- and epicardial TLS and GCS were lower in 
patients with significant CAD (Δ2.4 ± 3.6% and Δ6.7 ± 3.8%, p<0.001) than in those without 
significant CAD (Δ5.3 ± 2.1% and Δ10.4 ± 3.0%, p<0.001). This reflects a pronounced 
decrease in endocardial function in patients with significant CAD. Multivariate regression 
analyses including parameters influencing myocardial function showed that reduced 
myocardial function by endocardial TLS (per 1% change) was the only significant predictor 
(p<0.001) with odds ratio 2.10 (95% Confidence Interval 1.47-3.09) of the presence of 
significant CAD. ROC analysis showed that endo- and midmyocardial TLS were superior to 
identify significant CAD compared to epicardial TLS (p<0.05), WMSI (p<0.01) and EF 
(p<0.001) (Figure 10). 
Assessment of endo- and mid-myocardial territorial longitudinal strain by layer-
specific strain echocardiography provided higher accuracy than epicardial strain, WMSI and 
EF in the identification of patients with NSTE-ACS and significant CAD. Endocardial 
function was more affected in patients with significant CAD compared to epicardial function. 
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Figure 10. Receiver-operating characteristic curve analyses for the ability of Troponin T, EF, 
WMSI and TLS parameters to identify patients with significant coronary artery disease. The 
analyses include all study participants (n=77).35 
  
35 
 
DISCUSSION 
 
This thesis introduces new principles in the assessment of myocardial function. The 
prediction of clinical outcome in different cardiac diseases has long been a primary focus of 
cardiologists. Different cardiologic diseases have different pathophysiological background, 
however, many of these share a final common pathway, namely myocardial dysfunction.  
Patients with ARVC, HTx recipients and patients with significant CAD showed 
reduced myocardial function assessed by different strain echocardiographic methods, even 
though EF was generally within normal range. In all 3 studies, reduced myocardial function 
by strain was associated with increased myocardial disease and consequently worse 
prognosis. These findings indicate that subtle myocardial abnormalities induced by different 
myocardial diseases may be detected by sensitive echocardiographic techniques and improved 
prognostic information can be achieved. 
Mechanisms of reduced myocardial function in ARVC patients, HTx 
recipients and patients with CAD  
 
The mechanisms of reduced myocardial function in ARVC patients, HTx recipients 
and patients with CAD have both similarities and differences. Myocardial dysfunction in 
patients with CAD has primarily regional, while in HTx recipients and patients with ARVC a 
combination of global and regional character. 
ARVC is mainly an autosomal dominant inherited disease. Mutations in the genes 
encoding desmosomal proteins lead to cytoskeleton dysfunction, cell death and fibrosis.12 
Importantly, reduced myocardial function and malignant arrhythmias origin from different 
mechanisms at different stages of the disease. In the concealed phase, inflammatory processes 
due to apoptosis, derangements in cell-to-cell adhesion and altered nuclear signaling are 
present and may induce arrhythmias even though structural abnormalities may not be detected 
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by traditional imaging.12, 40 In later stages, fibro-fatty replacement of myocardial tissue is 
responsible for reduced myocardial function and for potential re-entry circuits.41-44  
In HTx recipients, myocardial function is determined by alloimmune response, and a 
variety of non-immune factors such as ischemia-reperfusion injury, post-surgical sympathetic 
denervation, reduction of pre-HTx pulmonary hypertension and LV preload, acute renal 
failure, advanced age, post-transplantation infections, and donor variables including age, 
ischemic time and LV hypertrophy.45-49 The mentioned factors influence the myocardium in 
different ways, however, rejection is the leading cause of allograft dysfunction in these 
patients.46 Rejection is characterized histologically by inflammatory cell infiltrates, interstitial 
edema and myocyte necrosis which ultimately translate into structural and functional 
abnormalities of the allograft.50  
In patients with significant CAD there are also several mechanisms leading to reduced 
myocardial function. Importantly, the main reason for reduced function is the imbalance 
between myocardial oxygen consumption and supply. The most obvious cause of this 
imbalance is coronary artery occlusion leading to irreversible myocardial cell death and 
fibrosis. On the other hand, reversible myocardial dysfunction can be induced by myocardial 
stunning or hibernation.51, 52 Myocardial stunning occurs in patients with significant coronary 
artery stenosis after episodes of ischemia. Recurrent episodes of, or prolonged ischemia and 
repetitive stunning may lead to chronic, but still reversible myocardial dysfunction known as 
myocardial hibernation.51, 53    
As described above, we have examined 3 fundamentally different patient groups. The 
pathophysiology leading to myocardial dysfunction is essentially different in these groups, 
however, the reduced ability of the myocardium to contract is shared in these diseases. 
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Mechanical dispersion and biventricular dysfunction in ARVC 
 
Electrical dispersion (heterogeneous electrical conduction) is a known arrhythmogenic 
factor.15 Electrical dispersion leads to mechanical abnormalities. Mechanical abnormalities 
can be assessed by 2D-STE as mechanical dispersion (heterogeneous contraction).16-18 
Paper 1 demonstrated that mechanical dispersion is pronounced in both ventricles in 
patients with ARVC and arrhythmias. Interestingly, reduced myocardial function by strain 
and increased mechanical dispersion in both ventricles were also present in asymptomatic 
ARVC mutation carriers. These findings suggest biventricular involvement also in the 
concealed phase of the disease when structural and functional changes are not apparent if 
assessed by traditional echocardiography or MRI. Importantly, the occurrence of malignant 
arrhythmias and reduced myocardial function can precede structural myocardial changes 
shown by traditional imaging techniques. An accurate assessment of myocardial function is 
therefore particularly important in early ARVC and in so far asymptomatic ARVC mutation 
carriers.  
Since the disease is inherited in at least 50% of cases,40 the screening of relatives is 
essential. Cascade genetic screening helps to identify affected family members and to focus 
resources. Still, risk stratification of asymptomatic ARVC mutation positive family members 
is challenging and is emphasized by the fact that the first manifestation of the disease in 20-
50% of cases may be cardiac arrest.  
The novelty of Paper 1 is the identification of myocardial abnormalities in 
asymptomatic ARVC mutation carriers and the potential for prediction of arrhythmias. 
Mechanical dispersion and strain by 2D speckle-tracking echocardiography appears to be a 
sensitive tool for assessing subtle changes in myocardial function and timing of myocardial 
contraction in ARVC patients and in asymptomatic ARVC mutation carriers.  
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Myocardial function in HTx recipients 
 
In Paper 2, we have shown that assessment of LV function by echocardiographic 
global longitudinal strain is a sensitive marker of poor clinical outcome. Reduced deformation 
assessed by strain was the only non-invasive independent predictor of 1-year mortality in 
heart transplant recipients, together with the well established invasive prognostic variable of 
pulmonary vascular resistance. 
But why is LV function reduced in these HTx non-survivors? A transplanted heart is 
never fully compatible with its new host. Therefore, one could in theory expect a development 
of low degree chronic rejection status even if it is not necessarily detectable by biopsy. The 
degree of rejection is clearly dependent on the grade of immune incompatibility and the 
efficacy of immune suppression. Increasing grade of acute rejection (or combination of the 2 
different rejection types) has obviously increasing detrimental effect on LV function.50 
According to our results in Paper 2, markedly reduced myocardial function was present 
already early after HTx in patients who developed fulminant rejection and graft failure later 
on, even though rejection was detectable by endomyocardial biopsy in only 1 patient at the 
time of the echocardiographic study.  
On the other hand, all HTx non-survivors without rejections had complications 
directly or indirectly affecting myocardial function and hemodynamics, and had accordingly 
reduced LV function. In addition, many of these non-survivors developed multiple organ 
dysfunction syndrome early after HTx and had increased pulmonary vascular resistance.  
Early changes of allograft rejection might be detected by 2D-STE.54 The results of 
Paper 2 imply that a single assessment of LVGLS early after HTx might be a useful non-
invasive screening tool in the identification of HTx recipients with poor clinical prognosis. 
Interestingly, HTx survivors with only modestly reduced or normal LV function by 
LVEF had markedly reduced function by LVGLS. Reduced LV function assessed by LVGLS 
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early after HTx, despite normal LVEF, might be explained by non-immune factors, described 
earlier, besides alloimmune response, and is in accordance with reports demonstrating a 
higher sensitivity for the detection of incipient heart failure by LVGLS compared to LVEF.55 
Function in different myocardial layers in patients with CAD 
 
Paper 3 demonstrated impaired LV function in all 3 myocardial layers in patients with 
NSTE-ACS and significant CAD compared to patients without significant CAD. 
Interpretation of ECG changes could not distinguish between patients with and without 
significant CAD. These results confirm earlier studies and suggest that assessment of layer-
specific strain may increase the accuracy in the attempts to identify significant CAD before 
referral to angiography and can be of valuable help as an additional clinical tool in the 
diagnostic work-up of these patients. 
About two thirds of coronary angiographies lead to an intervention in patients with 
NSTE-ACS.23 Although, there are several different non-invasive methods for the purpose of 
identifying significant CAD, 56 many of these are expensive, unavailable and the number of 
false positive and negative test results are high.  
In patients with CAD, the inner oblique myocardium is most susceptible to ischemic 
injury.57 Myocardial infarction models as well as reperfusion studies of myocardial infarction 
have indicated that the endocardial layer is first affected by ischemia25 causing morphologic24 
and functional alterations predominant in this layer. With increasing severity, ischemia and 
necrosis propagate in a transmural wavefront extending from the endocardium to the 
epicardium. 26 Due to the fact that greatest shortening in a healthy myocardium occurs in the 
endocardial layer and that endocardium is first affected by ischemia, one will expect that 
significant CAD causes greatest reduction of function in this particular layer. Reduced 
endocardial function in patients with significant CAD can be explained by either coronary 
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occlusion and direct myocardial damage or by reversible myocardial dysfunction caused by 
myocardial stunning or hibernation.53   
In study 3, endocardial longitudinal and circumferential strains were better than 
epicardial strains to identify patients with significant CAD. Furthermore, our results indicate 
that all 3 myocardial layers were affected by both coronary artery occlusion and by significant 
coronary artery stenosis, however to different extent. The greatest decrease in myocardial 
function, occurred in the endocardial layer since shortening normally is most prominent in 
this layer. Therefore, layer-specific strain analyses might increase diagnostic accuracy in these 
patients. 
Methodology: strain by 2-dimensional speckle-tracking 
echocardiography 
 
 Total wall thickness strain, layer-specific strain and mechanical dispersion were 
assessed by 2D-STE. The advantage of strain echocardiography, is that it assesses myocardial 
deformation, an intrinsic mechanical property, and therefore is a more direct measure of 
function than conventional cavity-based echocardiographic parameters such as EF. 
In this thesis, detailed strain studies were used to measure subtle alterations in 
myocardial function in various ways. In ARVC patients and asymptomatic ARVC mutation 
carriers, we determined timing of maximal myocardial contractions in different myocardial 
segments and calculated mechanical dispersion, which showed to be related to ventricular 
arrhythmias. In HTx recipients, reduced myocardial function by strain was detected before 
these patients developed fulminant allograft rejection. Finally, evaluation of layer-specific 
deformation showed a pronounced reduction in endocardial function and transmural 
deformation gradient in patients with significant CAD. In these papers, a combination of 
previous knowledge of pathophysiology and use of echocardiographic techniques gave 
valuable prognostic information.  
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Speckle tracking technique as used in these papers is attractive and robust in use. 
Reproducibility and feasibility studies including timing and strain measurements were 
satisfying. 
Importantly, in all 3 studies subtle myocardial alterations were detected with strain 
echocardiographic methods, even if reduced myocardial function was typically absent when 
assessed by traditional imaging techniques. This thesis shows that strain echocardiographic 
evaluation may add important prognostic information in patients with subtle myocardial 
alterations. 
LIMITATIONS 
Limitations of 2D speckle-tracking echocardiography 
 
The method, 2D-STE, used in all 3 studies is a promising tool for the evaluation of 
myocardial function, however, it has several limitations.58 
Feasibility is often mentioned as a limitation of 2D-STE for several reasons. The 
speckles, used in the process of strain assessments, are created by the constructive and 
destructive interferences of ultrasound backscattered from structures smaller than the 
ultrasound wavelength. Artifacts resembling speckles will influence the quality of speckle 
tracking. The method is sensitive to acoustic shadowing or reverberations, which may result 
in the underestimation of deformation. Reduced signal quality and suboptimal tracking may 
also create nonphysiological strain traces. To avoid this, spatial smoothing and previous 
knowledge of physiologic LV function are used in tracking algorithms. This, however, may 
incorrectly show regional dysfunction or affect neighboring segmental strain values. Speckle 
tracking is especially challenging in structures with thin wall, such as the RV free wall (Paper 
1) and in structures which are difficult to define, such as the 3 myocardial layers (Paper 3). In 
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case of too many discarded segmental strain values, global strain might be inaccurate. This is 
especially true in localized myocardial diseases where strain values are unevenly distributed. 
Although, more angle independent than tissue Doppler imaging, 2D-STE is not 
completely angle independent. Ultrasound images typically have better resolution along the 
ultrasound beam compared with directions at right angles. Therefore, speckle tracking works 
better for assessments of deformation in the direction along the ultrasound beam than in other 
directions. This property makes the use of longitudinal strain measurements particularly 
attractive, since myocardial motion is typically parallel with the ultrasound beam (Paper 1-3). 
Non-physiological strain traces may also arise when morphologic details can`t be 
tracked from one frame to the next due to out of plane motion of speckles. This phenomenon 
is a natural consequence of the 3 dimensional nature of myocardial deformation. Speckles 
move in 3 and not 2 dimensions. 
A major limitation of the current use of 2D-STE is the differences among vendors. 
One important difference between the technologies in Toshiba and GE, the 2 vendors used in 
our studies, is that strain calculations in Toshiba are mainly based on information from the 
endocardial layer while GE`s are primarily from the mid-myocardial layer.  
The discrepancy between vendors is clearly demonstrated by the significant difference 
between the total wall thickness LVGLS [-22 (-21, -24) %] in healthy controls in Paper 1 by 
GE scanner and endocardial LVGLS [-20 (-17, -21) %] (p<0.05) in patients without 
significant CAD in Paper 3 by Toshiba scanner. Physiologically, one would expect higher 
endocardial longitudinal deformation than total wall thickness longitudinal deformation in 
healthy individuals. Although, the selection of individuals in these 2 groups were somewhat 
different, the discrepancy in strain might be the result of the difference in scanners. 
Nevertheless, in an earlier study, the 2 commercially available speckle-tracking softwares in 
question appeared to be comparable when quantifying LV function in a healthy population.59 
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Importantly, the parameter, global longitudinal strain, which was primarily used in our 
studies, is a more robust parameter than radial and circumferential strain for the assessment of 
myocardial function when Toshiba`s and GE`s cardiac ultrasound systems are used for 
analysis.59 
Due to variance between strain values between vendors, a joint workgroup of the 
American Society of Echocardiography (ASE), the European Association of 
Echocardiography (EAE) and representatives of all Medical Imaging vendors will work for a 
standardization of strain values from different scanners.  The algorithms used by the different 
software packages are similar in terms of the speckle-tracking analysis, which is based on a 
block-matching approach of the speckle patterns within the myocardium, however, the strain 
calculation formulas used are somewhat varying. There are presently ongoing trials with the 
different scanners using the same formula for strain calculations. 
Finally, changes in hemodynamic parameters such as preload, afterload and 
contractility may influence strain measurements.60 In paper 1 and 3, patients were 
hemodynamically stable. However, in paper 2, strain measurements in HTx recipients 1-3 
weeks after heart transplantation may have been influenced by hemodynamic instability. 
Study specific limitations 
 
The first 2 studies were retrospective in their design, with the limitations inherent in 
this methodology.  
The echocardiographic data were analyzed blinded to all clinical information in all 3 
studies. However, in the first study ICD leads were visible on echocardiography, thus 
demasking the disease status of the patients. 
We assessed LVGLS in the first 2 studies but not radial or circumferential strain. This 
measure was chosen because longitudinal strain has been best validated, measurements are 
reproducible and are easily obtained. In addition, radial and circumferential strains from the 
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right ventricle are more difficult to obtain due to the complicated anatomy (Paper 1). In the 
third study we did not have 3 short axis projections available for the assessment of 
circumferential strain in a 16 segments model. Therefore, 16 longitudinal segments analyzed 
by strain were compared with only 6 mid circumferential segments. The latter performed 
poorer in the diagnosis of significant CAD, probably due to the undetected distal and to some 
extent mid-coronary stenoses and occlusions which predominantly influence apical and to a 
certain degree mid-myocardial function.  
The follow up in the second paper is limited to 1 year. The echocardiographic image 
quality is often reduced in the early post-operative phase. However, we were able to assess 
LVGLS in most of our HTx patients (Paper 2).  
All patients with suspected NSTE-ACS  in Paper 3 were treated according to 
guidelines at admission. Obviously, this could have caused dissolvement of thrombi allowing 
recovery of the affected myocardium. However, one may also speculate that even in case of 
dissolvement of thrombi, the myocardium might be still stunned or hibernated within the first 
48 hours. Furthermore, it is not known if coronary artery occlusions represent transmural or 
non-transmural infarctions since no viability studies have been performed on our patients. 
Fractional flow reserve measurements were not performed in all patients, therefore the true 
hemodynamic relevance of the stenoses is not known (Paper 3). 
Deformation of the entire wall thickness of the myocardium has not been assessed in 
Paper 3 since the software (Toshiba Medical Systems Corporation, Tokyo, Japan) did not 
allow such analysis. Consequently, we could not evaluate if layer-specific strain analysis has 
additional value compared to traditional total wall thickness strain analysis in diagnosing 
CAD. 
The gradient of strain across the myocardium is a non linear phenomena and the 
definition of the layers is arbitrary and is based on simple division into 3 parts. Since the 
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spatial resolution of ultrasound is limited, there will always be a certain degree of “overlap” 
(Paper 3).  
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CONCLUSIONS 
General conclusion 
 
Strain echocardiography is a sensitive tool in the early detection of subtle myocardial 
alterations in patients with ARVC, HTx recipients and patients with significant CAD. 
Specific conclusion 
 
I. RV and LV mechanical dispersion by myocardial strain was pronounced in patients 
with ARVC with ventricular arrhythmias and was present in asymptomatic mutation 
carriers, therefore mechanical dispersion may be helpful in risk stratification in these 
patients (Paper 1).  
 
II. ARVC patients with arrhythmias showed significantly reduced RV and LV function 
assessed by myocardial strain compared to asymptomatic mutation carriers and 
healthy controls. LV and RV function by strain were correlated in these patients 
implying that ARVC is a biventricular disease. RV and LV function was reduced in 
asymptomatic mutation carriers compared to healthy individuals (Paper 1). 
 
III. Reduced LVGLS assessed by strain echocardiography, 1-3 weeks after heart 
transplantation was the only non-invasive independent predictor of 1-year mortality in 
heart transplant recipients, together with the well established invasive prognostic 
variable of pulmonary vascular resistance (Paper 2). 
. 
IV. Assessment of endo- and midmyocardial territorial longitudinal strain by layer-specific 
strain echocardiography provided higher accuracy than epicardial territorial 
longitudinal strain, wall motion score index and ejection fraction in the indentification 
of significant CAD in patients with suspected NSTE-ACS (Paper 3).  
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